NCT00957255

Brief Summary

Prospective, randomized, multi-center, controlled study for patients undergoing open rotator cuff repair. Patients are stratified based on tear size to one of three groups. Each group is then randomized 1:1 to either repair with OrthoADAPT or repair without OrthoADAPT.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2009

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2009

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 11, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 12, 2009

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2010

Completed
Last Updated

April 5, 2017

Status Verified

April 1, 2017

Enrollment Period

1.1 years

First QC Date

August 11, 2009

Last Update Submit

April 4, 2017

Conditions

Keywords

rotator cuff tearrotator cuff repair

Outcome Measures

Primary Outcomes (4)

  • Passive and active range of motion

    Pre-op, 6 weeks, 3, 4, 6, 12, and 24 months

  • American Shoulder and Elbow Surgeons assessment score

    Pre-op, 6 weeks, 3, 4, 6, 12, and 24 months

  • Constant shoulder score

    Pre-op, 6 weeks, 3, 4, 6, 12, and 24 months

  • Pain

    Pre-op, 2, 3, 4, and 6 weeks, 3, 4, 6, 12 and 24 months

Secondary Outcomes (3)

  • MRI

    12 months

  • Rotator cuff re-rupture and adhesions

    6 weeks, 3, 4, 6, 12 and 24 months

  • Incidence of device or procedure related adverse events

    6 weeks, 3, 4, 6, 12, and 24 months

Study Arms (2)

RCR without augmentation

ACTIVE COMPARATOR

Rotator cuff repair without OrthoADAPT augmentation

Procedure: Standard of care

RCR with augmentation

EXPERIMENTAL

Rotator cuff repair with OrthoADAPT augmentation

Device: OrthoADAPT

Interventions

soft tissue augmentation device

RCR with augmentation

Standard of care rotator cuff repair

RCR without augmentation

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ages 18-70
  • MRI confirmed full thickness or high grade partial thickness rotator cuff tear equal or more than 1 cm and involving the supraspinatus and/or infraspinatus tendons
  • Tear is repairable by surgery using protocol prescribed fixation procedure
  • Patient is able to sign and IRB approved study informed consent
  • Patient is willing and able to return for follow-up appointments and study related procedures
  • Patient is willing to comply with prescribed physical therapy regimen

You may not qualify if:

  • Emergency, poly trauma patients
  • Prior same shoulder surgery including rotator cuff repair except prior subacromial decompression or distal clavicle resection
  • Shoulder pathology requiring concomitant procedures during the rotator cuff repair including Labral repair, anterior or posterior stabilization, and/or capsular plication or shift
  • Cervical spine disease
  • History of adhesive capsulitis in either shoulder
  • Patient whose injury does or may involve litigation
  • Diabetics
  • Rotator cuff tear cannot be repaired by primary surgical means including superiorly migrated humeral head, retracted rotator cuff that cannot be mobilized to humeral head, end stage tears, rotator cuff tissue cannot retain sutures, any comorbidities that would directly or indirectly affect the reparability of the cuff
  • Patients with grade 3 or 4 glenohumeral arthritis
  • Patients with systemic collage disease
  • Patients with a known hypersensitivity to equine derived materials
  • Active or latent infection
  • Chronic use of immunosuppressive agents
  • Any oral or IM NSAID usage within 5 days before surgery
  • Cancer patients
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seattle Medical Research Foundation

Seattle, Washington, 98104, United States

Location

MeSH Terms

Conditions

Rotator Cuff Injuries

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

RuptureWounds and InjuriesShoulder InjuriesTendon Injuries

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Charles DePaolo, MD

    Mission Health Research Institute

    PRINCIPAL INVESTIGATOR
  • Pierce Scranton, MD

    Seattle Medical Research Foundation

    PRINCIPAL INVESTIGATOR
  • William Bryan, MD

    Methodist Center for Orthopedic Surgery

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 11, 2009

First Posted

August 12, 2009

Study Start

March 1, 2009

Primary Completion

April 1, 2010

Study Completion

April 1, 2010

Last Updated

April 5, 2017

Record last verified: 2017-04

Locations